Published in Toxicon on August 01, 1992
Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science (2011) 4.72
Antecedents of the people and organizational aspects of medical informatics: review of the literature. J Am Med Inform Assoc (1997) 4.10
Privately funded quality health care in India: a sustainable and equitable model. Int J Qual Health Care (2001) 3.65
Managing change: an overview. J Am Med Inform Assoc (2000) 3.33
Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem (1991) 3.20
Persistent abdominal pain. Treatment by nerve block. Anaesthesia (1971) 2.33
Coexistence of superconductivity and ferromagnetism in two dimensions. Phys Rev Lett (2011) 2.29
Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol (1997) 2.19
Tomotherapy. Semin Radiat Oncol (1999) 2.16
The duration of ambulatory visits to physicians. J Fam Pract (1999) 2.06
Cyclopiazonic acid inhibition of the Ca2+-transport ATPase in rat skeletal muscle sarcoplasmic reticulum vesicles. Biochem Pharmacol (1988) 1.85
Ankylosing spondylitis: lateral approach to spinal anaesthesia for lower limb surgery. Can J Anaesth (1995) 1.63
Iodine deficiency and neonatal hypothyroidism. Bull World Health Organ (1986) 1.57
Frequency of infectious gastrointestinal illness in Australia, 2002: regional, seasonal and demographic variation. Epidemiol Infect (2006) 1.53
Assignment of two loci for autosomal dominant adolescent idiopathic scoliosis to chromosomes 9q31.2-q34.2 and 17q25.3-qtel. J Med Genet (2007) 1.48
Interaction of cyclopiazonic acid with rat skeletal muscle sarcoplasmic reticulum vesicles. Effect on Ca2+ binding and Ca2+ permeability. Biochem Pharmacol (1989) 1.47
Nutritional management of diarrheal diseases. Indian Pediatr (1996) 1.40
Bioavailability and bioequivalence: an FDA regulatory overview. Pharm Res (2001) 1.39
Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy. Gut (1983) 1.37
Overt colon ischemia after endovascular aneurysm repair: the importance of microembolization as an etiology. J Vasc Surg (2001) 1.36
Oral pathoses as diagnostic indicators in leukemia. Oral Surg Oral Med Oral Pathol (1980) 1.35
Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument. Br J Dermatol (2014) 1.29
Complications of total hip arthroplasty: MR imaging-initial experience. Radiology (2000) 1.29
Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ Health Perspect (2001) 1.29
Alternative methods of treating pain. Anaesthesia (1978) 1.24
Increasing incidence of midterm and long-term complications after endovascular graft repair of abdominal aortic aneurysms: a note of caution based on a 9-year experience. Ann Surg (2001) 1.23
Retinal function in birdshot retinochoroidopathy. Acta Ophthalmol (Copenh) (1991) 1.22
Contamination and crossinfection with Clostridium difficile in an intensive care unit. Aust N Z J Med (1982) 1.19
Constrictive pericarditis. Clin Cardiol (1999) 1.17
Abdominal wall pain due to nerve entrapment. Practitioner (1971) 1.16
Internationally distributed frozen oyster meat causing multiple outbreaks of norovirus infection in Australia. Clin Infect Dis (2007) 1.13
Extradural block. Confirmation of the injection site by X-ray monitoring. Anaesthesia (1985) 1.12
The medical treatment of secretory otitis media. A clinical trial of three commonly used regimes. J Laryngol Otol (1977) 1.12
Fumonisins: fungal toxins that shed light on sphingolipid function. Trends Cell Biol (1996) 1.12
Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. Toxicol Appl Pharmacol (1992) 1.10
Improving community knowledge of obstetric fistula prevention and treatment. Int J Gynaecol Obstet (2007) 1.08
Adolescent girls' life aspirations and reproductive health in Nepal. Reprod Health Matters (2001) 1.07
Fumonisins and other inhibitors of de novo sphingolipid biosynthesis. Adv Lipid Res (1993) 1.06
An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme. Environ Health Perspect (2001) 1.04
Savins through the direct approach to jaundice. Am J Surg (1974) 1.01
Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity. Toxicol Appl Pharmacol (1996) 1.00
Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma. J Neurooncol (2005) 0.99
Barriers and resistance to informatics in behavioral health. Stud Health Technol Inform (2001) 0.98
Optically guided intensity modulated radiotherapy. Radiother Oncol (2001) 0.97
Patient outcomes. Are they linked to registered nurse absenteeism, separation, or work load? J Nurs Adm (1994) 0.97
Outbreaks of shigellosis in Denmark and Australia associated with imported baby corn, August 2007--final summary. Euro Surveill (2007) 0.96
Evaluation of CSF-adenosine deaminase activity in tubercular meningitis. J Assoc Physicians India (1999) 0.96
Epidemiological investigation of cholera outbreak in a periurban slum colony in Chandigarh. Indian J Med Sci (2001) 0.95
Efficacy of a proximal occlusion catheter with reversal of flow in the prevention of embolic events during carotid artery stenting: an experimental analysis. J Vasc Surg (2001) 0.94
Long term outcome for extra-anatomic arch reconstruction. An analysis of 143 procedures. Eur J Vasc Endovasc Surg (2007) 0.94
The conserved global regulator VeA is necessary for symptom production and mycotoxin synthesis in maize seedlings by Fusarium verticillioides. Plant Pathol (2012) 0.94
Maternal fumonisin exposure as a risk factor for neural tube defects. Adv Food Nutr Res (2009) 0.94
Spinal cord motoneuron excitability during isoflurane and nitrous oxide anesthesia. Anesthesiology (1997) 0.93
Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: fumonisin B(1) as an example. Toxicol Sci (2001) 0.92
Vertebral collapse following spinal anesthesia. Spine (Phila Pa 1976) (1991) 0.92
In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats. Mycopathologia (1998) 0.91
Structural studies of biomaterials using double-quantum solid-state NMR spectroscopy. Annu Rev Phys Chem (2002) 0.91
Knowledge and change in health care organizations. Stud Health Technol Inform (2000) 0.90
Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase. Toxicol Sci (2002) 0.90
Fumonisin toxicity and sphingolipid biosynthesis. Adv Exp Med Biol (1996) 0.89
Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B(1). Food Chem Toxicol (2000) 0.89
In vitro toxicology of fumonisins and the mechanistic implications. Mycopathologia (1992) 0.89
Injection into the extra-arachnoid subdural space. Experience in the treatment of intractable cervical pain and in the conduct of extradural (epidural) analgesia. Anaesthesia (1977) 0.89
Intubation conditions after atracurium and suxamethonium. Br J Anaesth (1983) 0.88
Neuropsychological deficits in tests of executive function in asymptomatic and symptomatic HIV-1 seropositive men. Psychol Med (1995) 0.88
Pharmacokinetic evaluation of drug interactions with zidovudine. I: Probenecid and zidovudine in monkeys. J Pharm Sci (1991) 0.88
Effects of intravenous fumonisin B1 in rabbits: nephrotoxicity and sphingolipid alterations. Nat Toxins (1995) 0.88
Importance of sphingolipids and inhibitors of sphingolipid metabolism as components of animal diets. J Nutr (1997) 0.88
Fumonisin B1 promotes aflatoxin B1 and N-methyl-N'-nitro-nitrosoguanidine-initiated liver tumors in rainbow trout. Toxicol Appl Pharmacol (2001) 0.88
Effects of triple antioxidant therapy on measures of cardiovascular autonomic neuropathy and on myocardial blood flow in type 1 diabetes: a randomised controlled trial. Diabetologia (2013) 0.86
Malignant paraganglioma of the prostate and retroperitoneum. J Urol (1979) 0.86
Current radiosurgery practice: results of an ASTRO survey. Task Force on Stereotactic Radiosurgery, American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys (1994) 0.86
Does the endovascular repair of aortoiliac aneurysms pose a radiation safety hazard to vascular surgeons? J Vasc Surg (2000) 0.86
Outbreaks of Shigella sonnei infections in Denmark and Australia linked to consumption of imported raw baby corn. Epidemiol Infect (2009) 0.86
A study of prevalence and pattern of hyperactive syndrome in primary school children. Indian J Psychiatry (1981) 0.86
Fumonisin B1 consumption by rats causes reversible, dose-dependent increases in urinary sphinganine and sphingosine. J Nutr (1999) 0.86
Central neurocytoma: a clinical study of response to chemotherapy. J Neurooncol (1997) 0.86
The history of the Intractable Pain Society of Great Britain and Ireland. Pain (1980) 0.85
Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice. J Biochem Mol Toxicol (1998) 0.85
Fumonisin toxicity and metabolism studies at the USDA. Fumonisin toxicity and metabolism. Adv Exp Med Biol (1996) 0.85
Screening of fungal species for fumonisin production and fumonisin-like disruption of sphingolipid biosynthesis. Mycopathologia (1999) 0.85
Trauma faculty and trauma team activation: impact on trauma system function and patient outcome. J Trauma (1999) 0.85
Effect of airway control by glottal structures on postural stability. J Appl Physiol (1985) (2013) 0.85
Subchronic toxic effects of Fusarium moniliforme and fumonisin B1 in rats and mice. Nat Toxins (1996) 0.85
The treatment of chronic back pain. A preliminary survey of the effect of radiofrequency denervation of the posterior vertebral joints. Anaesthesia (1979) 0.84
Tornwaldt's cyst: clinical and radiological aspects. J Otolaryngol (1987) 0.84
Intellectual assessment of school children from severely iodine deficient villages. Indian Pediatr (1987) 0.84
Essential pharmacokinetic information for drug dosage decisions: a concise visual presentation in the drug label. Clin Pharmacol Ther (2011) 0.83
Pharmacokinetic evaluation of drug interactions with anti-human immunotrophic virus (HIV) Drugs. III. 2',3'-Dideoxycytidine (ddC) and zidovudine in monkeys. Pharm Res (1992) 0.83
Loss of red blood cell glutathione during Mg deficiency: prevention by vitamin E, D-propranolol, and chloroquine. Am J Physiol (1994) 0.83
Role of dietary sphingolipids and inhibitors of sphingolipid metabolism in cancer and other diseases. J Nutr (1995) 0.83
Behavior of the H-reflex in humans following mechanical perturbation or injury to rostral spinal cord. Muscle Nerve (1996) 0.82
Spontaneous regression of a tectal mass in neurofibromatosis 1. AJNR Am J Neuroradiol (1998) 0.82
Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships. Toxicol Appl Pharmacol (1997) 0.82
Tumor necrosis factor-alpha as a contributor in fumonisin B1 toxicity. J Pharmacol Exp Ther (1998) 0.82
Effectiveness of ammonia treatment in detoxification of fumonisin-contaminated corn. Food Chem Toxicol (1991) 0.82
Cytokines, neuropeptides, and reperfusion injury during magnesium deficiency. Ann N Y Acad Sci (1994) 0.82
Fumonisin concentrations and in vivo toxicity of nixtamalized Fusarium verticillioides culture material: evidence for fumonisin-matrix interactions. Food Chem Toxicol (2008) 0.81